Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reo Tanoshima

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|September 19, 2023
Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 UpdateErika N Scott, Akshaya A Joseph, Angie Dhanda, et al.
Personalized Medicine|May 11, 2021
Deliberations about clinical pharmacogenetic testing in pediatric oncologyAmalia M Issa, Sarah Ae Aboushawareb, David D Eisenstat, et al.
Journal of Pediatric Hematology/Oncology|August 21, 2018
Intraventricular Rituximab in Pediatric CD20-positive Refractory Primary Central Nervous System LymphomaYuko Wada-Shimosato, Junji Ikeda, Shin-Ichi Tsujimoto, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|April 21, 2016
Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion GeneMayu Ishibashi, Tomoko Yokosuka, Masakatsu D Yanagimachi, et al.
Therapeutic Innovation & Regulatory Science|May 30, 2025
Diverse Roles and Characteristics of Academic Research Organizations in Japan: Results of A Questionnaire-Based StudyReo Tanoshima, Riki Tanaka, Koji Hara, et al.
Cancer Science|January 5, 2019
Genome-wide DNA methylation profiling shows molecular heterogeneity of anaplastic pleomorphic xanthoastrocytomaTaishi Nakamura, Kohei Fukuoka, Yoshiko Nakano, et al.
Journal of Clinical Immunology|August 29, 2023
Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical FeaturesDaisuke Kurita, Norio Shiba, Takashi Ohya, et al.
Journal of Clinical Pharmacology|November 20, 2018
Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety DatabaseReo Tanoshima, Amna Khan, Agnieszka K Biala, et al.
Blood Advances|January 12, 2022
Phenotypic heterogeneity in individuals with MECOM variants in 2 familiesTetsuya Niihori, Reo Tanoshima, Yoji Sasahara, et al.
International Journal of Hematology|November 19, 2013
Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapyMasakatsu Yanagimachi, Hiroaki Goto, Tetsuji Kaneko, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|September 19, 2023
Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 UpdateErika N Scott, Akshaya A Joseph, Angie Dhanda, et al.
Personalized Medicine|May 11, 2021
Deliberations about clinical pharmacogenetic testing in pediatric oncologyAmalia M Issa, Sarah Ae Aboushawareb, David D Eisenstat, et al.
Journal of Pediatric Hematology/Oncology|August 21, 2018
Intraventricular Rituximab in Pediatric CD20-positive Refractory Primary Central Nervous System LymphomaYuko Wada-Shimosato, Junji Ikeda, Shin-Ichi Tsujimoto, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|April 21, 2016
Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion GeneMayu Ishibashi, Tomoko Yokosuka, Masakatsu D Yanagimachi, et al.
Therapeutic Innovation & Regulatory Science|May 30, 2025
Diverse Roles and Characteristics of Academic Research Organizations in Japan: Results of A Questionnaire-Based StudyReo Tanoshima, Riki Tanaka, Koji Hara, et al.
Cancer Science|January 5, 2019
Genome-wide DNA methylation profiling shows molecular heterogeneity of anaplastic pleomorphic xanthoastrocytomaTaishi Nakamura, Kohei Fukuoka, Yoshiko Nakano, et al.
Journal of Clinical Immunology|August 29, 2023
Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical FeaturesDaisuke Kurita, Norio Shiba, Takashi Ohya, et al.
Journal of Clinical Pharmacology|November 20, 2018
Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety DatabaseReo Tanoshima, Amna Khan, Agnieszka K Biala, et al.
Blood Advances|January 12, 2022
Phenotypic heterogeneity in individuals with MECOM variants in 2 familiesTetsuya Niihori, Reo Tanoshima, Yoji Sasahara, et al.
International Journal of Hematology|November 19, 2013
Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapyMasakatsu Yanagimachi, Hiroaki Goto, Tetsuji Kaneko, et al.
Pageof 5